NFκB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation

Cancer Biology and Therapy

Volumn 8, Issue 9, 2009, Pages 765-773

  Madhusoodhanan, Rakhesh ^a   Natarajan, Mohan ^b   Veeraraghavan, Jamunarani ^a   Herman, Terence S ^a   Aravindan, Natarajan ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Fractionated irradiation; MCF 7; NF B DNA binding activity; Radiation induced molecular signaling; Radio adaptive response; Transcriptional responses after FIR

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERLEUKIN 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BAK; PROTEIN BID; PROTEIN KINASE B; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS; BIRC3 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; SUPEROXIDE DISMUTASE; XIAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CELL CYCLE REGULATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DNA BINDING; DNA REPAIR; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN PHOSPHORYLATION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIVITY; SENESCENCE; SIGNAL TRANSDUCTION; ADENOCARCINOMA; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; RADIATION DOSE; TUMOR CELL LINE;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE FRACTIONATION; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; RADIATION DOSAGE; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 68149164689     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.9.8105     Document Type: Article

References (54)

1. Tsai MH, Cook JA, Chandramouli GV, DeGraff W, Yan H, Zhao S, et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 2007; 67:3845-52.
2. Morgan WF. Is there a common mechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionizing radiation? Oncogene 2003; 22:7094-9.
3. Ch'ang HJ, Maj JG, Paris F, Xing HR, Zhang J, Truman JP, et al. ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med 2005; 11:484-90.
4. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33:781-96.
5. Jameel JK, Rao VS, Cawkwell L, Drew PJ. Radioresistance in carcinoma of the breast. Breast 2004; 13:452-60.
6. Ahmed KM, Dong S, Fan M, Li JJ. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol Cancer Res 2006; 4:945-55.
7. Mitra AK, Krishna M. Fractionated and acute irradiation induced signaling in a murine tumor. J Cell Biochem 2007; 101:745-52.
8. Pearce AG, Segura TM, Rintala AC, Rintala-Maki ND, Lee H. The generation and characterization of a radiation-resistant model system to study radioresistance in human breast cancer cells. Radiat Res 2001; 156:739-50.
9. Joiner MC. Evidence for induced radioresistance from survival and other end points: an introduction. Radiat Res 1994; 138:S5-8.
10. Amundson SA, Bittner M, Meltzer P, Trent J, Fornace AJ, Jr. Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat Res 2001; 156:657-61.
11. Li Z, Xia L, Lee LM, Khaletskiy A, Wang J, Wong JY, et al. Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat Res 2001; 155:543-53.
12. Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 2001; 61:7585-93.
13. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Int J Radiat Oncol Biol Phys 2004; 58:542-54.
14. Aravindan N, Madhusoodhanan R, Natarajan M, Herman TS. Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells. Mol Cell Biochem 2008; 310:167-79.
15. Natarajan M, Aravindan N, Meltz ML, Herman TS. Post-translational modification of I-kappa B alpha activates NF-kappa B in human monocytes exposed to 56Fe ions. Radiat Environ Biophys 2002; 41:139-44.
16. Aravindan N, Madhusoodhanan R, Ahmad S, Johnson D, Herman TS. Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 2008; 569-76.
17. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27:131-46.
18. Henness S, Davey MW, Harvie RM, Davey RA. Fractionated irradiation of H69 smallcell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. Int J Radiat Oncol Biol Phys 2002; 54:895-902.
19. Weichselbaum RR, Beckett MA, Dahlberg W, Dritschilo A. Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones. Int J Radiat Oncol Biol Phys 1988; 14:907-12.
20. Joiner MC, Lambin P, Malaise EP, Robson T, Arrand JE, Skov KA, et al. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat Res 1996; 358:171-83.
21. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98:1777-85.
22. Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 2005; 65:7169-76.
23. Rotman G, Shiloh Y. ATM: from gene to function. Hum Mol Genet 1998; 7:1555-63.
24. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996; 86:159-71.
25. Wang YA, Elson A, Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci USA 1997; 94:14590-5.
26. Kastan MB. Cell cycle. Checking two steps. Nature 2001; 410:766-7.
27. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001; 410:842-7.
28. Mazumder S, Gong B, Almasan A. Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells. Oncogene 2000; 19:2828-35.
29. Dulic V, Lees E, Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 1992; 257:1958-61.
30. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995; 15:4215-24.
31. Blattner C, Sparks A, Lane D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol Cell Biol 1999; 19:3704-13.
32. Baeuerle PA, Baltimore D. Hormonal control regulation of gene transcription. In molecular aspects of cellular regulation. Cohen P, Foulkes JG (eds), Elsevier/North Holland Biomedical Press Amsterdam 1991:409-32.
33. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissuespecific gene control. Cell 1989; 58:227-9.
34. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 1991; 67:1075-87.
35. Yeoh A, Gibson R, Yeoh E, Bowen J, Stringer A, Giam K, et al. Radiation therapyinduced mucositis: relationships between fractionated radiation, NF-kappaB, COX-1, and COX-2. Cancer Treat Rev 2006; 32:645-51.
36. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, et al. Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci USA 1993; 90:9901-5.
37. Tozawa K, Sakurada S, Kohri K, Okamoto T. Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res 1995; 55:4162-7.
38. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R, Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest 1991; 88:691-5.
39. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3:401-10.
40. Cao C, Mu Y, Hallahan DE, Lu B. XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 2004; 23:7047-52.
41. Ravi R, Bedi A. NF-kappaB in cancer - a friend turned foe. Drug Resist Updat 2004; 7:53-67.
42. Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, Kasarskis EJ, et al. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 1999; 18:709-22.
43. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 2003; 23:2362-78.
44. Epperly MW, Gretton JA, DeFilippi SJ, Greenberger JS, Sikora CA, Liggitt D, et al. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD2-PL) gene therapy. Radiat Res 2001; 155:2-14.
45. Ross HJ, Canada AL, Antoniono RJ, Redpath JL. High and low dose rate irradiation have opposing effects on cytokine gene expression in human glioblastoma cell lines. Eur J Cancer 1997; 33:144-52.
46. Konemann S, Bolling T, Malath J, Kolkmeyer A, Janke K, Riesenbeck D, et al. Timeand dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation. Int J Radiat Biol 2003; 79:897-909.
47. Neta R. Modulation of radiation damage by cytokines. Stem Cells 1997; 15 Suppl 2:87-94.
48. Renard P, Raes M. The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies. Cell Biol Toxicol 1999; 15:341-4.
49. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 2003; 284:F608-27.
50. Shah SA, Potter MW, McDade TP, Ricciardi R, Perugini RA, Elliott PJ, et al. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J Cell Biochem 2001; 82:110-22.
51. Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, et al. Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. Oncogene 2003; 22:1365-70.
52. Le X, Shi Q, Wang B, Xiong Q, Qian C, Peng Z, et al. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J Interferon Cytokine Res 2000; 20:935-46.
53. Niu J, Li Z, Peng B, Chiao PJ. Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J Biol Chem 2004; 279:16452-62.
54. Takahashi H, Funahashi H, Sawai H, Sakamoto M, Matsuo Y, Yamamoto M, et al. Glial cell line-derived neurotrophic factor enhances nuclear factor-kappaB activity and invasive potential in human pancreatic cancer cells. Pancreas 2004; 29:22-7.